Latest News


Crystec to present at Inhalation Asia 2019, 13-15 November, Hong Kong - Thumbnail Image

Crystec to present at Inhalation Asia 2019, 13-15 November, Hong Kong

Inhalation Asia is a non-commercial conference that aims to provide an opportunity for people who work on pulmonary and intranasal drug delivery in Asia to network and showcase their research, products and services. The event will take place at the Hong Kong Science and Technology Park in Sha Tin.

Meet with Crystec at CPhI Worldwide, November 2019 - Thumbnail Image

Meet with Crystec at CPhI Worldwide, November 2019

CrystecPharma are attending CPhI in Frankfurt in November, where CEO, Paul Thorning, will participate on the pane of “The Future of Medicine: What are the therapies of tomorrow?”. Contact us today to schedule a meeting at the event, to learn more about how we could help you to improve product performance and accelerate development timelines.

CrystecPharma win Making Pharmaceuticals Award for Innovation in Manufacturing - Thumbnail Image

CrystecPharma win Making Pharmaceuticals Award for Innovation in Manufacturing

Crystec are honoured to have been awarded the Making Pharmaceuticals Award for Innovation in Manufacturing. The award was presented for Crystec’s mSAS® (modified Supercritical Anti-Solvent) technology and chosen from shortlisted companies including kg-pharma, iDi Pac, Glatt Protech and SSPC, Bernal Institute.

What does 2019 have in store for Pharma? - Thumbnail Image

What does 2019 have in store for Pharma?

Crystec’s CEO, Paul Thorning, has contributed to an article by UBM featuring the big issues affecting Pharma for 2019, according to key opinion leaders in the industry. Contributors include representatives from PharmSource, Catalent Pharma Solutions and NIBRT.